Family Smoking Cessation in Romania Using Pregnancy as a Window of Opportunity (QuitTogether)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02512913|
Recruitment Status : Recruiting
First Posted : July 31, 2015
Last Update Posted : April 18, 2019
|Condition or disease||Intervention/treatment||Phase|
|Tobacco Smoking Pregnancy||Behavioral: Adapted/enhanced MAPS||Not Applicable|
Pregnancy smoking and postnatal relapse are highly prevalent in Romania and Central and Eastern Europe, with lifetime negative health effects for the women and their children. There are higher odds of female smoking persistence during pregnancy, and of relapse once pregnant women quit, when the male partner also smokes.
Building on ongoing pilot work led by Dr. Meghea with Babes-Bolyai University (BBU) in Cluj-Napoca, Romania, the overall objective of the proposed research, conducted through BBU in the same target population as the ongoing pilot, is to adapt, enhance, and test the implementation feasibility and preliminary efficacy of an evidence-based pregnancy and postnatal couple intervention for smoking cessation that begins early in pregnancy and has a postnatal component.
The intervention will be based on the motivation and problem solving (MAPS) approach, successful in preventing smoking relapse postpartum in the US, which will be enhanced by targeting the couples' smoking behavior by focusing on dyadic efficacy for smoking cessation. The target population is primigravida pregnant women and their partners in Cluj-Napoca, Romania.
The specific aims are: (1) To develop an adapted and enhanced couple intervention to reduce pregnancy smoking and postpartum relapse in Romania based on the MAPS approach. (2) To conduct a pilot randomized controlled trial to test the fidelity of the culturally adapted MAPS intervention enhanced for couples smoking prevention during pregnancy and postpartum. (3) To examine in the pilot the implementation feasibility and initial efficacy in increasing maternal pregnancy smoking cessation and reducing postnatal relapse, with secondary hypotheses regarding maternal smoking reduction and spousal cessation, relapse, and reduction.
This study will form the basis for a larger, multicenter clinical trial that will be submitted by Dr. Meghea as an R01 application by the end of the 4th year of this award to evaluate the effectiveness of the proposed smoking prevention intervention. If proven effective in the subsequent R01 trial, the intervention has a high potential for broad spectrum population impact and sustainability. The long-term goal is the adoption in the national Romanian health system as a proactive extension of the existing STOP SMOKING national program which includes a quitline.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||430 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Investigator, Outcomes Assessor)|
|Official Title:||Family Smoking Cessation in Romania Using Pregnancy as a Window of Opportunity|
|Actual Study Start Date :||November 25, 2015|
|Estimated Primary Completion Date :||May 2020|
|Estimated Study Completion Date :||May 2020|
Experimental: Adapted/enhanced MAPS
Counseling sessions delivered by phone to the pregnant/postpartum women and to the husbands/partners
Behavioral: Adapted/enhanced MAPS
The plan is for recruitment at the first prenatal care visit followed by a proposed eight-session phone counseling sequence for the women, consistent with the session frequency in the original MAPS intervention: 1st call at 14 weeks gestation (75% of Romanian women begin prenatal care in 1st trimester), three monthly calls through the 2nd trimester (18-22-26 weeks gestation), a 5th and 6th calls in the 3rd trimester (32 and 36 weeks), and two postnatal calls (2 and 6 weeks postpartum). Four calls are planned for the partners: at 14-, 22-, and 32-weeks, and at 2-weeks postpartum.
No Intervention: Usual Care
Couples in the control condition will receive usual care
- maternal smoking abstinence (questionnaire, biochemical verified) [ Time Frame: assessments at recruitment, at 32-weeks during pregnancy, and at 16 weeks after birth ]assessed at multiple time points during the project
- maternal smoking abstinence (questionnaire) [ Time Frame: assessments at recruitment, at 32-weeks during pregnancy, and 16 weeks after birth ]assessed at multiple time points during the project
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02512913
|Contact: Cristian Meghea, PhD||2487161043||Cristian.Meghea@hc.msu.edu|
|Contact: Oana M Blaga, PhD (c)||firstname.lastname@example.org|
|Cluj-Napoca, Cluj, Romania, 400301|
|Contact: Oana M Blaga, PhD(c) 0749240017 email@example.com|
|Principal Investigator:||Cristian Meghea, PhD||Michigan State University|